Inventory: listed instrument company's performance this year, the performance of domestic and foreign companies is very different
Instrument company executives have said at Pittcon 2015 that a strong dollar impact will hit their bottom line. I don't want to say a word, the US dollar exchange rate has become the biggest "blocker" for the growth of the 2015 listed Q1 financial report of various US listed instruments. Table 1 2015 listed Q1 performance of foreign listed instrument companies Of course, the most severely affected by the strong US dollar exchange rate is the US listed instrument company. The exchange rate issue was mentioned in the Q1 earnings report of 11 US listed instrument companies in Table 1, with a negative impact of 3-11%. Affected by this, one of the 11 US-listed instrument companies showed double-digit growth, three were single-digit growth, one was basically flat, and the remaining six companies all experienced negative growth. The only company with double-digit growth was Illumina, which was once named the "best company" in the world. Although it was also affected by exchange rate fluctuations, the company still had a 28% increase in the first quarter of this year, the highest growth rate in the industry. At the moment, global gene sequencing technology and the market continue to be hot, and the growth rate of Illumina's future performance will be unstoppable. The most affected by the exchange rate is Brooke, and exchange rate fluctuations have brought about a 11% negative impact on its Q1 performance. Coupled with last year's departmental restructuring plan, multiple product line divestiture and NMR performance sluggish factors, Brooke Q1 performance showed a 17% sharp decline. Of course, in the face of the strong rebound of the US dollar exchange rate, the German listed instrument companies in the euro zone have benefited, such as Sartorius, Germany Jena Q1 earnings growth rate of more than 25%. Of course, the main reason for its rapid growth in performance is the strong performance of its own business. The growth of product service in Sartorius laboratory is strong, and the growth of biotechnology solution business is far more than expected. Benefiting from China's two major orders, Jena analytical instrument in Germany /Life sciences business strongly reversed Q1 performance. Table 2 Domestic listed instrument company's 2015 Q1 results Back to the domestic market, affected by a wave of policy dividends, the performance of many domestic listed instrument companies Q1 has grown rapidly. Among them, 8 companies have experienced double-digit growth, and Hanwei Electronics Q1 has surged 93%. In addition, there were two households with single-digit growth and one with basic parity. At the same time, due to the sluggish demand from domestic industrial users, the performance of the three domestic listed instrument companies Q1 was negative, and the performance of science and technology monitoring fell the most. It is worth noting that this year's statistical form has added two new members - Nanhua Instrument and Su test. As the new instrument stocks of the 2015 GEM, Nanhua Instruments and the Su test Q1 performed well, with growth rates of 26% and 34% respectively. At present, the policy dividends are stimulated and the corporate capital continues to be abundant. The confidence and strength of domestic listed instrument companies' mergers and acquisitions have increased significantly. Since the beginning of 2015, domestic listed instrument companies have continuously staged the acquisition of integrated drama, or transformed into services, or improved the industrial chain, or entered the internationalization. In March, Concentration Technology took 105 million yuan to control Xinlili and entered the water treatment market. Now, Guangguang Technology is planning major events and is in a suspension period. In April, Tianrui Instrument's 135 million acquisitions were environmentally friendly, strategically cut into environmental protection and environmental protection operations, and got rid of the single identity of instrument suppliers. In May, Xianhe Environmental Protection acquired a 60% stake in Sunset Company of US$6.6 million and strategically placed the market for carbon aerosol analysis. The new three-board Haineng Instrument acquired Shanghai Xinyi to create a new future for domestic microwave chemical instruments. June was even more buzzing. First, Bohui invested $28 million to acquire Advion, the US mass spectrometer, and plans to develop a suitable mass spectrometer for medical diagnostics. Then, Siddilong announced that 15.66 million yuan will hold a 51% stake in British mass spectroker Kore, and strive to build a domestic time-of-flight mass spectrometer to prepare for VOCs monitoring business opportunities. Mass spectrometry instruments have always been the "short handle" products in domestically produced instruments. Nowadays, more and more domestic instrument manufacturers are crowding into the mass spectrometer circle. I believe that in the near future, domestic instrument manufacturers will bring more mass specs to users. "! It can prevent some medicine or blood from splashing on the face, thus protecting the eyes. This kind of glasses is generally used in conjunction with masks and surgical caps to fully protect the doctor's head.
4. The breathability must be good, generally there are vents
Protective goggles,disposable medical equipment,personal protection,daily protection Shanghai Rocatti Biotechnology Co.,Ltd , https://www.ljdmedical.com
[Functions of medical eye masks]
1. Prevent blood, potion and other liquids that cause damage to the skin from causing unpredictable damage to the eyes.
2. It can prevent the impact of objects on the eyes during close surgery.
3. The inner space of the eye mask is large enough for doctors who wear myopia glasses.
